Taking CRISPR Safety to the Next Level
Gene therapies are experiencing a new era. CRISPR is current. CRISPR is trendy. CRISPR is…
11/12/2019 - 7 minutes
CRISPR
CRISPR Cell Therapy Shows Early Promise for Treating Blood Disorders
CRISPR Therapeutics and its US partner Vertex Pharmaceuticals have released the first clinical results for…
19/11/2019 - 3 minutes
Novo Nordisk and Bluebird Bio to Treat Hemophilia with Gene Editing
The Danish big pharma Novo Nordisk has joined forces with the US gene therapy company…
09/10/2019 - 1 minute
This Biotech Can Screen CAR T-Cells Using Only Light and Microfluidics
Based in Cambridge, UK, Lightcast Discovery is developing microfluidics technology that automates cell screening experiments…
27/09/2019 - 3 minutes
Swiss Scientists Upgrade CRISPR to Edit Many Genes at Once
A research group at ETH Zurich, Switzerland, has made it possible to edit hundreds of…
15/08/2019 - 3 minutes
CRISPR Therapeutics and Vertex Seal Deal Worth up to €890M
The US giant Vertex Pharmaceuticals is expanding an existing collaboration with the Swiss company CRISPR…
07/06/2019 - 2 minutes
‘CRISPR Babies’ Might Be at Risk of Dying Younger
Update (01/10/2019): The scientists behind the study have declared that the results were based on…
03/06/2019 - 3 minutes
This Biotech Uses Gene Editing to Count Chickens Before They Hatch
In the city of Jerusalem, eggXYt is developing gene edited chickens whose male chicks fluoresce…
24/05/2019 - 3 minutes
2019 Will Be a “Year of Realism” for Biotech Investments
Biotech investors regularly jump on new crazes, including the microbiome and CRISPR-Cas9 gene editing. At…
06/05/2019 - 6 minutes
Viruses Evolve to Defeat CRISPR-Cas9 in Genetically-Modified Plants
Researchers found that viral pathogens can quickly evolve to overcome transgenic cassava plants expressing the…
29/04/2019 - 2 minutes
Francis Mojica, the Spanish Scientist Who Discovered CRISPR
Contrary to popular belief, Francis Mojica was the first person to discover the CRISPR mechanism…
08/04/2019 - 11 minutes
Danish Biotech to Develop CRISPR-Based Microbiome Treatments
SNIPR Biome has raised €43M in Series A funds to develop treatments that precisely target…
11/03/2019 - 2 minutes
